Kamedis, a provider of products for the treatment of chronic skin disorders, announced the addition of Kamal Abbasi to its board of directors. Abbasi formerly served as area vice president of Nestle Skin Health’s Galderma business for Asia Pacific. He is currently vice president at Sinclair Pharma with responsibility for Asia Pacific, Middle East/North Africa and Central/Eastern Europe.
Abbasi, a British citizen, is a medical doctor and obtained his degree from the Sindh Medical University in Karachi, Pakistan. His appointment coincides with a major growth initiative by Kamedis in Central and Eastern Europe.
